Clinical Science coughs up $525,000 to settle Medicaid fraud allegations
September 10, 2010 by MassDevice staff
Clinical Science Laboratory Inc. will pay the Commonwealth of Massachusetts $525,000 to resolve allegations that it fraudulently billed Medicaid for urine-based drug tests.
Clinical Science Laboratory Inc. agreed to pay Massachusetts $525,000 to settle allegations that the company defrauded Medicaid.
Attorney General Martha Coakley's Medicaid fraud division found that the Mansfield, Mass.-based diagnostics firm billed the federal and state-funded social welfare program for unauthorized urine drug tests between 2004 and 2009, the AG's office said.
Similar entries
- Login to post comments
-
Permalink
FDA Database Search
RECENT BLOG POSTS
- Funding R&D: High prices, overuse a failed strategy
- FDA's role in promoting women's health
- New partnership to boost use of GMDN codes for medical devices
- FDA's modern "Corps of Discovery" in China
- Consumers lose in latest FDA user fee bill; COI restraints disappear
- Gamification
- Cool technology of the week
- A new day: Interim thoughts on the 2012 Heart Rhythm Society scientific sessions
- When a child loses milestones, consider sleep EEG studies
- Red or blue pill for payment reform? Both won't work
NEWS
MassDevice.com +3 | The top 3 med-tech stories for May 15, 2012.
Boston Scientific's Lotus TAVI system minimizes leakage in an early trial, St. Jude Medical gains on...
Electromed CEO Robert Hansen retires after 20 years at the helm | Personnel Moves
Electromed founder, chairman & CEO Robert Hansen announces his retirement after 20 years leading...
St. Jude Medical gains on Goldman upgrade | Wall Street Beat
St. Jude Medical's shares get a 2% lift from an upgrade by a Goldman Sachs analyst.
SEC closed probe of Zoll's Middle East sales just ahead of $2.3B Asahi merger
Just weeks before a $2.3 billion acquisition by Asahi Kasei closed, the Securities & Exchange...
Boston Scientific's Synergy bioabsorbable stent stands up to Promus Element
Boston Scientific's Synergy bioabsorbable drug-eluting stent proves just as good as its leading and...
